
SFDA hosts their 1st meeting of Arab Authorities Controlling Medicines, promoting Arab integration in the field of medicines control and legislation. Topics discussed included registration procedures, monitoring safety and quality, and the role of medicines control labs. Coordination and alignment with legal and regulatory requirements for medicines are key to facilitating availability and lowering costs for patients.
Recent Posts
Closing the East-West Divide: Addressing Healthcare Investment Disparities in Central and Eastern...
A recent study commissioned by EFPIA and authored by leading CEE academics—Dr. Slaveyko Djambazov, Dr. Luka Voncina, Dr. Aleš Rod, and Dr. Marcin Czech—reveals that despite accelerated public health spending growth in several CEE countries, structural underinvestment persists. This produces marke...
Safeguarding Access: Navigating Pharmaceutical Cost Pressures in Portugal
Pharmaceutical cost pressures are mounting in Portugal, with industry leaders warning that price increases for certain medicines appear inevitable in the medium term despite the government’s commitment to strict controls in the 2026 annual review.
Global Cost Drivers Threaten Generic...
Inequality-Adjusted ICER: Enhancing Cost-Effectiveness in Health Technology Evaluation
The inequality-adjusted ICER offers a practical way to embed explicit trade-offs between maximising total population health and reducing health inequality directly into cost-effectiveness analysis. By dividing the conventional ICER by an inequality-adjusted ICER, analysts derive a health inequali...